山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
39期
8-11
,共4页
冯惠平%贾新未%王艳飞%张芳%张兰芳%解俊敏
馮惠平%賈新未%王豔飛%張芳%張蘭芳%解俊敏
풍혜평%가신미%왕염비%장방%장란방%해준민
洛伐他汀%醛固酮%一氧化氮%一氧化氮合酶%心肌成纤维细胞
洛伐他汀%醛固酮%一氧化氮%一氧化氮閤酶%心肌成纖維細胞
락벌타정%철고동%일양화담%일양화담합매%심기성섬유세포
Lovastatin%aldosterone%nitric oxide%nitric oxide synthase%cardiac fibroblasts
目的:探讨洛伐他汀对醛固酮诱导心肌成纤维细胞( CFs)增殖及诱导型一氧化氮合酶-一氧化氮( iN-OS-NO)系统活性的调控作用。方法用胰酶消化法分离、培养新生SD大鼠CFs,采用MTT比色法、硝酸还原酶法、分光光度法和半定量RT-PCR技术,观察不同浓度洛伐他汀对CFs增殖、NO含量、iNOS活性和iNOS mRNA表达的影响。结果洛伐他汀(1×10-8~1×10-5 mol/L)能剂量依赖性抑制醛固酮诱导CFs的增殖,升高CFs的NO含量、iNOS活性及增加iNOS mRNA的表达(P均<0.05),甲羟戊酸(1×10-3 mol/L)、法尼酯焦磷酸(5μmol/L)可完全逆转洛伐他汀的上调作用。洛伐他汀干预下醛固酮诱导CFs的NO生成量与iNOS活性、iNOS活性与iNOS mRNA表达均呈正相关(r分别为0.826、0.752,P均<0.01);CFs增殖数目与NO含量呈负相关(r=-0.908,P<0.01)。结论洛伐他汀可上调醛固酮诱导CFs的iNOS-NO系统活性,抑制CFs增殖,并呈剂量依赖性,其作用机制可能与甲羟戊酸途径调节有关。
目的:探討洛伐他汀對醛固酮誘導心肌成纖維細胞( CFs)增殖及誘導型一氧化氮閤酶-一氧化氮( iN-OS-NO)繫統活性的調控作用。方法用胰酶消化法分離、培養新生SD大鼠CFs,採用MTT比色法、硝痠還原酶法、分光光度法和半定量RT-PCR技術,觀察不同濃度洛伐他汀對CFs增殖、NO含量、iNOS活性和iNOS mRNA錶達的影響。結果洛伐他汀(1×10-8~1×10-5 mol/L)能劑量依賴性抑製醛固酮誘導CFs的增殖,升高CFs的NO含量、iNOS活性及增加iNOS mRNA的錶達(P均<0.05),甲羥戊痠(1×10-3 mol/L)、法尼酯焦燐痠(5μmol/L)可完全逆轉洛伐他汀的上調作用。洛伐他汀榦預下醛固酮誘導CFs的NO生成量與iNOS活性、iNOS活性與iNOS mRNA錶達均呈正相關(r分彆為0.826、0.752,P均<0.01);CFs增殖數目與NO含量呈負相關(r=-0.908,P<0.01)。結論洛伐他汀可上調醛固酮誘導CFs的iNOS-NO繫統活性,抑製CFs增殖,併呈劑量依賴性,其作用機製可能與甲羥戊痠途徑調節有關。
목적:탐토락벌타정대철고동유도심기성섬유세포( CFs)증식급유도형일양화담합매-일양화담( iN-OS-NO)계통활성적조공작용。방법용이매소화법분리、배양신생SD대서CFs,채용MTT비색법、초산환원매법、분광광도법화반정량RT-PCR기술,관찰불동농도락벌타정대CFs증식、NO함량、iNOS활성화iNOS mRNA표체적영향。결과락벌타정(1×10-8~1×10-5 mol/L)능제량의뢰성억제철고동유도CFs적증식,승고CFs적NO함량、iNOS활성급증가iNOS mRNA적표체(P균<0.05),갑간무산(1×10-3 mol/L)、법니지초린산(5μmol/L)가완전역전락벌타정적상조작용。락벌타정간예하철고동유도CFs적NO생성량여iNOS활성、iNOS활성여iNOS mRNA표체균정정상관(r분별위0.826、0.752,P균<0.01);CFs증식수목여NO함량정부상관(r=-0.908,P<0.01)。결론락벌타정가상조철고동유도CFs적iNOS-NO계통활성,억제CFs증식,병정제량의뢰성,기작용궤제가능여갑간무산도경조절유관。
Objective To investigate the effects of Lovastatin on the aldosterone-induced proliferation of rat cardiac fi-broblasts(CFs) and the activity of inducible nitric oxide synthase (iNOS).Methods CFs were isolated from neonatal Sprague Dawley rats by trypsin digestion.MTT colorimetric assay was used to evaluate cell proliferation.Nitric acid reduc-tase method, spectrophotometry and reverse transcription-polymerase chain reaction were used to detect the NO contents, iNOS activity and iNOS mRNA expression respectively.Results Lovastatin(1 ×10 -8 -1 ×10 -5 mol/L) inhibited the proliferation of CFs increased NO contents and iNOS activity in a dose-depend manner(P<0.05), which could be reversed by mevalonate(1 ×10 -3 mol/L) or farnesyl pyrophosphate(5μmol/L).NO contents and iNOS activity, iNOS activity and iNOS mRNA expression were positively correlate induced by different concentrations of Lovastatin(r=0.826, 0.752, re-spectively, all P<0.01).The proliferation of CFs was significant negatively correlated with NO contents induced by differ-ent concentrations of Lovastatin(r=-0.908, P<0.01).Conclusions The results indicate that Lovastatin up-regulated iNOS-NO system in CFs, and inhibite proliferation of CFs in a dose-depenent manner, which can be related to the regula-tion of mevalonate pathway.